Intravenous administration of human amnion-derived mesenchymal stem cells improves gait and sensory function in mouse models of spinal cord injury.

Front Cell Dev Biol · 2024 · PMC11422150 · PMID 39324071

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an increasing trendno p-value reported

The quantification of TSG6 showed an increasing trend with hAMSC treatment, but no significant difference was observed (2.04 ± 0.37, P = 0.10 , Figure 4D ).

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.